VHH albumin half-life extention
A humanised VHH antibody that binds to Human Serum Albumin with nanomolar affinities and can be easily combined with alternative VHH molecules
A Valuable Addition for Antibody Therapeutics
Coupling of drugs to Human Serum Albumin offers the opportunity to control and fine-tune the pharmacokinetic qualities without altering functional activity of the antibody molecules.
Iso-XTend™ half life extension
- FcRn-mediated serum half-life extension
Enables small, felxible molecules
Avoids low affinity Fc Receptor binding
Easily formatted for versatile applications
Partnerships at Isogenica
Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including one clinical Phase II asset and numerous partnered pre-clinical and discovery programs.